Atrial natriuretic factor inhibits adenylate cyclase activity.
The synthetic atrial natriuretic factor (ANF) (8- 33AA ) inhibited adenylate cyclase activity in aorta washed particles, mesenteric artery, and renal artery homogenates in a concentration dependent manner with an apparent Ki between 0.1 to 1nM . The extent of inhibition of adenylate cyclase by ANF varied from tissue to tissue. The adenylate cyclase from mesenteric artery and renal artery was inhibited to a greater extent as compared to that from aorta. ANF was also able to inhibit the stimulatory effects of hormones on adenylate cyclase activity and of agents such as F- and forskolin which activate adenylate cyclase by receptor- independent mechanism. In addition, ANF showed an additive effect with the inhibitory response of angiotensin II on adenylate cyclase from rat aorta. These studies for the first time demonstrate that ANF is an inhibitor of adenylate cyclase of several systems.
D000067956:Adenylyl Cyclase Inhibitors; D000818:Animals; D001011:Aorta / Q000201:enzymology; D006325:Heart Atria; D066298:In Vitro Techniques; D008638:Mesenteric Arteries / Q000201:enzymology; D009132:Muscles / Q000201:enzymology; D009206:Myocardium / Q000201:enzymology; D045283:Natriuretic Agents; D011506:Proteins / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D012077:Renal Artery / Q000201:enzymology; D012508:Sarcolemma / Q000201:enzymology
D000067956:Adenylyl Cyclase Inhibitors; D045283:Natriuretic Agents; D011506:Proteins